Showing results (11-20 of 415) with videos related to
Sort By:
Pageof 42
Hematology. American Society of Hematology. Education Program|December 10, 2013
JAK inhibition in the myeloproliferative neoplasms: lessons learned from the bench and bedsideJason GotlibCurrent Opinion in Hematology|January 15, 2010
Eosinophilic myeloid disorders: new classification and novel therapeutic strategiesJason GotlibHematology/Oncology Clinics of North America|July 5, 2017
Tyrosine Kinase Inhibitors in the Treatment of Eosinophilic Neoplasms and Systemic MastocytosisJason GotlibAmerican Journal of Hematology|October 19, 2017
World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and managementJason GotlibImmunology and Allergy Clinics of North America|August 26, 2006
KIT mutations in mastocytosis and their potential as therapeutic targetsJason GotlibBlood|March 10, 2022
Treatment and clinical endpoints in polycythemia vera: seeking the best obtainable version of the truthJason GotlibAmerican Journal of Hematology|August 29, 2012
World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and managementJason GotlibCancer Treatment and Research|February 21, 2008
Chronic eosinophilic leukemia/hypereosinophilic syndromeJason GotlibAmerican Journal of Hematology|March 1, 2014
World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and managementJason GotlibPageof 42